|
Comparison of TEMA and APM for antimycobacterial susceptibility testing of Non-tubercular mycobacterial isolates |
||||||||||||||
| APM |
||||||||||||||
|
|
||||||||||||||
| STR |
RIF |
ETH |
CIP |
OFL |
ATH |
CLA |
||||||||
|
|
|
|
|
|
|
|
||||||||
| TEMA |
S |
R |
S |
R |
S |
R |
S |
R |
S |
R |
S |
R |
S |
R |
|
|
||||||||||||||
| Sensitive |
43 |
1 |
45 |
0 |
36 |
0 |
50 |
0 |
53 |
0 |
43 |
0 |
45 |
0 |
| Resistant |
1 |
10 |
1 |
9 |
0 |
19 |
0 |
5 |
1 |
1 |
1 |
11 |
1 |
9 |
| Total |
44 |
11 |
46 |
9 |
36 |
19 |
50 |
5 |
54 |
1 |
44 |
11 |
46 |
9 |
| Percentage |
(80%) |
(20%) |
(83.6%) |
(16.4%) |
(65.5%) |
(34.5%) |
(91%) |
(9%) |
(98.2%) |
(1.8%) |
(80%) |
(20%) |
(83.6%) |
(16.4%) |
|
|
||||||||||||||
| Concordance |
96.4% |
98% |
100% |
100% |
98% |
98% |
98% |
|||||||
|
TEMA: Tetrazolium Microplate Assay, STR: Streptomycin, RIF: Rifampicin, ETH: Ethambutol, CIP: Ciprofloxacin, OFL: Ofloxacin, ATH: Azithromycin, CLA: Clarithromycin, S: Sensitive, R: Resistant. | ||||||||||||||
Sankar et al. Annals of Clinical Microbiology and Antimicrobials 2008 7:15 doi:10.1186/1476-0711-7-15 |
||||||||||||||